Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04940416 · ClinicalTrials.gov registry record
Eye Movement Testing for Diagnosing Encephalopathy in Patients With Liver Disease
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 48
- Enrollment target
NCT04940416: Clinical Trial study, sponsored by Stanford University.
NCT04940416 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04940416 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 48 participants
- Enrollment target
Study Summary
This study involves utilizing a noninvasive computer application (Neurofit) that performs oculometric assessment of dynamic visual processing in patients with liver cirrhosis to see if the presence of advance liver disease influences eye movement metrics.
Primary Outcome
Composite oculometric test result
Interventions
- DEVICE Neurofit (oculometric testing)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2017-08-31 |
| Est. Completion | 2021-06-17 |
Why NCT04940416 stopped before completion
NCT04940416 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Neurofit (oculometric testing) is the first listed.
NCT04940416 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04940416 about?
NCT04940416 is a clinical study titled "Eye Movement Testing for Diagnosing Encephalopathy in Patients With Liver Disease". This study involves utilizing a noninvasive computer application (Neurofit) that performs oculometric assessment of dynamic visual processing in patients with liver cirrhosis to see if the presence of advance liver disease influences eye movement metrics.
What is the current status of trial NCT04940416?
This trial is currently terminated. The enrollment target is 48 participants. The study started on 2017-08-31. Estimated completion is 2021-06-17.
What interventions are being tested in trial NCT04940416?
The interventions under investigation include: Neurofit (oculometric testing) (DEVICE).
Who is sponsoring clinical trial NCT04940416?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI